Sexual Toxicity of Cancer Drugs; Guilt and Non-Beneficial Care; Effects of Cannabis

MedPage Today) — Cancer drugs’ sexual toxicity warrants a “call to action” among oncologists to address the problem. (Lancet Oncology)
U.S. medical centers have appealed to the FDA for compassionate use approval of the adenosine receptor inhibitor…
Read More